Ascendis Pharma
ASND
ASND
103 hedge funds and large institutions have $2.51B invested in Ascendis Pharma in 2018 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 30 increasing their positions, 40 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.64% less ownership
Funds ownership: 96.05% → 95.41% (-0.64%)
12% less capital invested
Capital invested by funds: $2.85B → $2.51B (-$338M)
25% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 40
Holders
103
Holding in Top 10
13
Calls
$58.1M
Puts
$29.8M
Top Buyers
| 1 | +$45.7M | |
| 2 | +$11.6M | |
| 3 | +$9.63M | |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$8.47M |
| 5 |
Bank of New York Mellon
New York
|
+$7.73M |
Top Sellers
| 1 | -$61.5M | |
| 2 | -$25.5M | |
| 3 | -$9.38M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$6.26M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$5.07M |